Mr. Aaron Mullaniff:

It is a little like the Covid approach. Every country is taking a completely different approach. Canadians are currently working a Bill for a national vision strategy through their Government. The global leaders on this are Australia, Singapore, the United Kingdom and Canada. Australia has major screening programmes across age-related macular degeneration, AMD, and diabetic retinopathy. Singapore has the most advanced eye healthcare system in the world. The UK is using guidelines for detection, treatment and time to treatment, which are being consistently managed in the form of quality standards. As I said, the Canadians have universal healthcare and specific screening programmes that are targeting those who are at socioeconomic risk and indigenous populations.